Skip to content

Effects of different optical area sizes of orthokeratology lenses on myopia control and visual quality

Effects of different optical area sizes of orthokeratology lenses on myopia control and visual quality

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200061048
Enrollment
Unknown
Registered
2022-06-15
Start date
2022-06-01
Completion date
Unknown
Last updated
2023-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

myopia

Interventions

Two:Each subject's left and right eyes were randomly wore with bc 5mm or 6mm designed orthokeratology lenses

Sponsors

Tianjin Eye Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
9 Years to 12 Years

Inclusion criteria

Inclusion criteria: 1. Children and adolescents aged 9-12 years; 2. The bulboscopic degree of myopia in both eyes ranged from -1.00 to -4.00D (including -1.00D and -4.00D); 3. If astigmatism exists in both eyes, the normal astigmatism shall be less than or equal to 1.5D, and the inverse astigmatism shall be less than 1.00D; 4. The best corrected visual acuity of binocular subjective optometry is greater than or equal to 1.0; 5. Be able to understand the purpose of this clinical trial, voluntarily participate in and sign the informed consent form by their legal guardian, and be able to complete the follow-up on time.

Exclusion criteria

Exclusion criteria: 1. Suffering from systemic diseases that may affect the eyes, such as sinusitis, diabetes, Down syndrome, hyperthyroidism, rheumatoid arthritis or other diseases that researchers believe cannot wear corneal plastic lenses; 2. There are some eye diseases: such as acute or chronic eye inflammation, catarrhal conjunctivitis in spring, glaucoma, dry eyes with drug intervention within 30 days; 3. Those who need to use therapeutic eye drops at the same time, including antibiotics, corticosteroids and compound eye drops containing corticosteroids; 4. Abnormal intraocular pressure (intraocular pressure 21mmHg or binocular intraocular pressure difference >= 5mmHg); 5. Those who wear corneal shaping glasses or hard contact lenses within 30 days (including those who participate in the clinical trial) or those who participate in the clinical trial of soft hydrophilic contact lenses within 10 days; 6. Those who have participated in drug clinical trials within 90 days; 7. Use drugs that affect the wearing of eyes and corneal contact lenses; 8. Corneal surgery within 1 year; 9. Eyelid abnormality or infection; 10. Clinically meaningful slit lamp findings (see Annex III for specific requirements); 11. Those who have used contact lenses and / or nursing products for allergy; 12. The examination results showed that subjects with contraindications or unsuitable for wearing corneal shaping glasses; 13. Those who are unable to carry out eye examination regularly (or the guardian of the minor is unable to accompany the minor regularly); 14. The corneal flat curvature was lower than 39.00d or higher than 48.00d; 15. Other active eye diseases; 16. Number of endothelial cells < 2500 cells/cm2; 17. Tear film rupture time is less than or equal to 5S; 18. The researcher believes that it is not suitable to participate in this project.

Design outcomes

Primary

MeasureTime frame
Uncorrected visual acuity;Residual diopter (Expressed by equivalent sphericity);

Secondary

MeasureTime frame
Axial length;Corneal topography;Corneal endothelial cell count;Contrast sensitivity;Corneal biomechanics;Visual quality questionnaire;

Countries

China

Contacts

Public ContactChen Xiaoqin
chenxq017@163.com+86 18502681988

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jul 23, 2026